Pharmaceutical industry

Pfizer pays out to Nigerian families of meningitis drug trial victims

Sujets: 
Corruption, Pharmaceutical industry, Africa, Public health & safety
Scores: 
3
Anas Mustapha

David Smith – August 11, 2011

The parents of four Nigerian children who died of meningitis have become the first winners of a 15-year legal battle against Pfizer over a fiercely controversial drug trial.

The world's biggest research-based pharmaceutical company announced on Thursday that it had made payments of $175,000 (£108,000) to each family. More such compensation settlements are expected to follow.

U.S. Officials Hide Report on Antibiotics and Factory Farms

Sujets: 
Food safety, Pharmaceutical industry, Regulatory oversight, Food industry, Science
Scores: 
2

Tom Philpott – July 29, 2011

Here is a document the USDA doesn't want you to see. It's what the agency calls a "technical review"—nothing more than a USDA-contracted researcher's simple, blunt summary of recent academic findings on the growing problem of antibiotic-resistant infections and their link with factory animal farms.

The topic is a serious one. A single antibiotic-resistant pathogen, MRSA—just one of many now circulating among Americans—now claims more lives each year than AIDS.

MP Continues Fight for Improved Drug Safety

Sujets: 
Pharmaceutical industry, Regulatory oversight
Scores: 
4

Canada needs a more stringent drug-monitoring system, says critic

Trevor Maiman – July 22, 2011

Through a series of talks in several provinces, an Ontario MP is continuing his push for an independent agency to oversee the approval of pharmaceutical drugs in Canada.

Conservative MP Terence Young, author of “Death by Prescription,” returned late last week from his latest cross-Canada tour to expose what he calls “ongoing corporate malfeasance” that causes more than 200,000 deaths per year in North America.

Pharma Firm Settled to Avoid Long Court Battle, CEO Says

Sujets: 
Pharmaceutical industry
Scores: 
0

Frances Schwartzkopff – June 22, 2011

Novo Nordisk A/S settled drug marketing allegations this month to avoid a court battle with the U.S. government and can’t guarantee such charges won’t arise again, Chief Executive Officer Lars Rebien Soerensen said.

“We still maintain that we have done nothing wrong but a potential lawsuit with the government would be lengthy and costly and, considering the amount we would settle for, not in the interest of the company,” Soerensen said today by phone.

Drug firm's wooing made whistleblower suspicious

Sujets: 
USA, Pharmaceutical industry, Conflict of interest
Scores: 
2

Sig Christenson and Don Finley – June 26, 2011

Dr. Ian Black knows how far the pendulum can swing. Once a player in the world of trauma research, he became a pariah. Once a believer, he lost faith.

His journey from advocate of a drug that stopped bleeding in badly injured troops to federal whistleblower began in October 2005, around the time he attended a high-priced dinner at Emeril's restaurant in Atlanta not far from his room at the Ritz Carlton — all on the company tab, plus a $1,000 honorarium.

Reversal on drug trial disclosure policy draws fire

Sujets: 
Pharmaceutical industry
Scores: 
3

Tom Blackwell – May 29, 2011

The federal government’s medical-research funding agency has scrapped a new policy that required public disclosure of detailed drug-trial results, provoking international criticism and suggestions that the body buckled to pressure from pharmaceutical companies.

The Canadian Institute for Health Research (CIHR) policy, implemented last December, was designed to address allegations that companies cherry-pick trial results for publication to portray their medicines in the best light possible, sometimes keeping evidence of serious side effects under wraps.

CBC Tamiflu probe sparks drug policy review

Sujets: 
Pharmaceutical industry, Conflict of interest, Public health & safety
Scores: 
4

CBC News – May 23, 2011

The Public Health Agency of Canada is looking to make public the drug company affiliations — and therefore any potential conflict of interest — of its expert advisers, CBC News has learned.

This new direction was set out in an email over the holiday weekend to CBC/Radio-Canada reporter Frédéric Zalac and follows a months-long investigation by reporters from three different news organizations in three different countries into the effectiveness of the anti-viral drug Tamiflu and how it has been promoted.

Why is Health Canada failing to protect the public from superbugs?

Sujets: 
Food safety, Health Canada, Pharmaceutical industry, Regulatory oversight
Scores: 
3

February 21, 2011

The following letter was sent today to all members of the Agriculture and Agri-Food Committee.

Subject: Why is Health Canada failing to protect the public from superbugs?

A recent CBC Marketplace investigation provided dramatic evidence that Canada's food supply is badly tainted with superbugs -- deadly diseases that are resistant to antibiotics. Through programs like this one the public is increasingly becoming aware of this fact, and concerned that Health Canada does not seem to be doing its job.

The CBC investigators found that two-thirds of all chicken samples they purchased in Canadian supermarkets were contaminated with salmonella, campylobacter or e-coli -- and that in every single case these bugs were resistant to at least some antibiotics.

Steve Paikin interviews Terence Young, author of 'Death by Prescription'

Sujets: 
Health Canada, Pharmaceutical industry, Videos, Regulatory oversight
Scores: 
3
Terence Young

Steve Paikin interviews Terence Young about adverse drug reactions

Terence Young's 15-year old daughter Vanessa suddenly collapsed and died after taking prescription medication for bloating. Young embarked on a quest to uncover the truth about why she died. Steve Paiken finds out what Young learned about the pharmaceutical industry and the regulatory oversight of this industry in Canada. (16 minutes)

Pages

Subscribe to Pharmaceutical industry